Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domitille Gras

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 6, 2019
Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effectElodie Hainque, Domitille Gras, Aurélie Meneret, et al.
Developmental Medicine and Child Neurology|June 22, 2021
Opsoclonus-myoclonus in Aicardi-Goutières syndromeSalam Alburaiky, Russell C Dale, Yanick J Crow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2019
Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndromeElodie Hainque, Aurélie Meneret, Domitille Gras, et al.
European Journal of Medical Genetics|July 12, 2015
Inherited 1q21.1q21.2 duplication and 16p11.2 deletion: a two-hit case with more severe clinical manifestationsSophie Brisset, Yline Capri, Audrey Briand-Suleau, et al.
Clinical Genetics|June 20, 2020
Early-onset nucleotide excision repair disorders with neurological impairment: Clues for early diagnosis and prognostic counselingSarah Baer, Cathy Obringer, Sophie Julia, et al.
Movement Disorders Clinical Practice|July 21, 2023
Non-Motor Symptoms and Quality of Life in Patients with PRRT2-Related Paroxysmal Kinesigenic DyskinesiaAsya Ekmen, Mohamed Doulazmi, Aurélie Méneret, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 6, 2015
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiencyFanny Mochel, Elodie Hainque, Domitille Gras, et al.
Annals of Neurology|May 31, 2017
A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndromeDomitille Gras, Christelle Cousin, Caroline Kappeler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 10, 2024
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 StudyValentina De Giorgis, Kailash P Bhatia, Odile Boespflug-Tanguy, et al.
Neurology|June 30, 2012
PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European populationAurélie Méneret, David Grabli, Christel Depienne, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Neurology, Neurosurgery, and Psychiatry|April 6, 2019
Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effectElodie Hainque, Domitille Gras, Aurélie Meneret, et al.
Developmental Medicine and Child Neurology|June 22, 2021
Opsoclonus-myoclonus in Aicardi-Goutières syndromeSalam Alburaiky, Russell C Dale, Yanick J Crow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2019
Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndromeElodie Hainque, Aurélie Meneret, Domitille Gras, et al.
European Journal of Medical Genetics|July 12, 2015
Inherited 1q21.1q21.2 duplication and 16p11.2 deletion: a two-hit case with more severe clinical manifestationsSophie Brisset, Yline Capri, Audrey Briand-Suleau, et al.
Clinical Genetics|June 20, 2020
Early-onset nucleotide excision repair disorders with neurological impairment: Clues for early diagnosis and prognostic counselingSarah Baer, Cathy Obringer, Sophie Julia, et al.
Movement Disorders Clinical Practice|July 21, 2023
Non-Motor Symptoms and Quality of Life in Patients with PRRT2-Related Paroxysmal Kinesigenic DyskinesiaAsya Ekmen, Mohamed Doulazmi, Aurélie Méneret, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 6, 2015
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiencyFanny Mochel, Elodie Hainque, Domitille Gras, et al.
Annals of Neurology|May 31, 2017
A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndromeDomitille Gras, Christelle Cousin, Caroline Kappeler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 10, 2024
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 StudyValentina De Giorgis, Kailash P Bhatia, Odile Boespflug-Tanguy, et al.
Neurology|June 30, 2012
PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European populationAurélie Méneret, David Grabli, Christel Depienne, et al.
Pageof 4